Shareholder activism is on the rise, according to a new analysis released this morning by The Conference Board (and shared in ...

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

Masimo named Becton Dickinson executive Katie Szyman as its top boss, the medical device maker said on Tuesday, months after ...

Learn more about whether ICU Medical, Inc. or Masimo Corporation is a better investment based on AAII's A+ Investor grades, ...

Masimo ( ($MASI) ) has shared an announcement. On January 30, 2025, Robert Chapek, a member of the Board of Directors and Audit Committee of ...

Masimo Co. (NASDAQ:MASI – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven brokerages ...

Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Masimo Corporation (NASDAQ:MASI), a medical technology company valued at $9.36 billion, reported on Friday the resignation of board member Robert Chapek. The departure is set to take effect on the ...

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her ...